Insulet Corporation (PODD)

Acerca de Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Al 3 de noviembre de 2026, la acción de Insulet Corporation (PODD) subió a $156.56, un alza de 1.92% (+$2.94) frente al cierre anterior. En la sesión, las acciones han operado entre $151.23 y $156.59. Eso ubica a PODD en el tercio inferior de su rango de 52 semanas, de $126.40 a $354.88. Insulet Corporation opera en el sector de surgical & medical instruments & apparatus y tiene una capitalización de mercado de aproximadamente $10.65 mil millones, con cerca de 451.4 mil acciones negociadas.

Últimas noticias de PODD

• Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in LondonYahoo Finance· 3 nov, 7:00 a.m. ETGMT
• Insulet (PODD) Reports Next Week: Wall Street Expects Earnings GrowthYahoo Finance· 28 oct, 9:00 a.m. ET
• Insulet's Quarterly Earnings Preview: What You Need to Knowbarchart.com· 27 oct, 9:57 a.m. ET
• Insulet (PODD) Could Be 11% Undervalued On Omnipod Discover LaunchYahoo Finance· 26 oct, 2:07 a.m. ET
• DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT StudyYahoo Finance· 20 oct, 9:50 a.m. ET
• 2 Profitable Stocks to Keep an Eye On and 1 We QuestionYahoo Finance· 19 oct, 10:32 a.m. ET
• 2 of Wall Street’s Favorite Stocks to Target This Week and 1 We IgnoreYahoo Finance· 16 oct, 8:59 a.m. ET
• Insulet Announces Omnipod Discover Now Available in U.S.Yahoo Finance· 12 oct, 7:00 a.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de PODD en un solo lugar? Crea una cuenta gratis →

• Big support on $PODD monthly chart:

  @TradesWithTom· 29 oct, 3:27 p.m. ET

• $PODD 11/20 $155 call seeing nearly $1M in net buying. Reporting earnings on the morning of November 4th. ±12.15 implied move.

  @peloswing· 29 oct, 3:22 p.m. ET· Alcista

• $BBNX Going to be one of the best new product stories of 2027 in MedTech…buy every dip here. Headed to $30+. 🔥🦾 $DXCM $PODD $IHI $XLV

  @healthcareguru· 29 oct, 12:59 p.m. ET· Alcista

• 🎯 $PODD | BULLISH SETUP Healthcare / Medical Devices & Supplies 🐂 ⭐ Setup Quality Grade: A- 📌 Grade Justification: • Profitability: Premier Diabetes Tech Operator (~$10.4B market cap, $3.17B+ annual revenue, strong ~23.5% YoY top-line growth). • Revenue Growth: Omnipod …

  @OnlyFibs· 28 oct, 9:15 p.m. ET· Alcista

• The New Release. $PODD Like and Follow if you want more of this weekly!

  @MadMaverick· 25 oct, 12:04 a.m. ET· Alcista

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →